All posts by: Michael Zand

Hematopoietic stem cell transplantation did not affect survivorship after TKA – Healio

Insider FinancialHematopoietic stem cell transplantation did not affect survivorship after TKAHealioAlthough survivorship after total knee arthroplasty was not affected among patients with a history a hematopoietic stem cell transplantation, results pu… Continue reading

Stem cells hold the key to a better life for MS patient – Woodbury Bulletin

Woodbury BulletinStem cells hold the key to a better life for MS patientWoodbury BulletinRejected by the only certified stem cell treatment program in the United States at Northwestern Hospital in Chicago, Rivard discovered the Clinica Ruiz option thro… Continue reading

Stem cells hold the key to a better life for MS patient – Woodbury Bulletin

Woodbury BulletinStem cells hold the key to a better life for MS patientWoodbury BulletinRejected by the only certified stem cell treatment program in the United States at Northwestern Hospital in Chicago, Rivard discovered the Clinica Ruiz option thro… Continue reading

Menlo Ventures dives into data-driven health care investing with its newest partner – TechCrunch

Business Insider

Menlo Ventures dives into data-driven health care investing with its newest partner TechCrunch Early-stage venture firm True Ventures was among the earliest to jump into the space, making what seemed at the time to be unusual bets on synthetic biology and neurosciences and generally wading back into markets that had previously been difficult to … A $5 billion Silicon Valley VC is getting back into biotech and looking to back ‘iconic entrepreneurs’Business Insider UK Menlo Ventures banks on tech-driven life sciences, adds Greg Yap as new partnerVentureBeat Menlo Ventures adds Greg Yap as Partner to Focus on Life Science Technology InvestingGlobeNewswire (press release) all 4 news articles »

Business Insider

Menlo Ventures dives into data-driven healthcare investing with its newest partner TechCrunch Early-stage venture firm True Ventures was among the earliest to jump into the space, making what seemed at the time to be unusual bets on synthetic biology and neurosciences and generally wading back into markets that had previously been difficult to … A $5 billion Silicon Valley VC is getting back into biotech and looking to back ‘iconic entrepreneurs’Business Insider UK Menlo Ventures banks on tech-driven life sciences, adds Greg Yap as new partnerVentureBeat Menlo Ventures adds Greg Yap as Partner to Focus on Life Science Technology InvestingGlobeNewswire (press release) all 4 news articles »

Brainstorm Health: Most Powerful Women, CA Drug Pricing Law, Spark’s Gene Therapy Fortune Good morning, Dailies. I’m in Washington, D.C. today for Fortune’s annual gathering of the Most Powerful Women—a rare business summit that is, effectively, designed to preclude manterrupting, mansplaining, and recidivist hepeating. So, no surprise … and more »

Madison.com

Why CRISPR Therapeutics AG Stock Lost Ground in September Madison.com According to data from S&P Global Market Intelligence, shares of the gene-editing company CRISPR Therapeutics (NASDAQ: CRSP) dropped by 13.1% in September. CRISPR’s poor showing last month appears to stem from nothing more than investors … Next Capital Raising For CRISPR Therapeutics AG (CRSP)?Simply Wall St Street Analysts View On CRISPR Therapeutics AG (CRSP), China Life Insurance Company Limited (LFC)Post Analyst Crispr Therapeutics AG (CRSP) Expected to Announce Earnings of -$0.49 Per ShareBangaloreWeekly HugoPress –Hot Stocks Point –Highlight Press all 13 news articles »

Business Insider

A $5 billion Silicon Valley VC is getting back into biotech and looking to back ‘iconic entrepreneurs’ Business Insider Specifically, the plan will be to invest in companies that are in diagnostics, genomics, digital health, synthetic biology, and have a data-driven platforms for drug discovery. So far, Menlo has invested in Synthego, Cofactor Genomics, Clear Labs … Menlo Ventures banks on tech-driven life sciences, adds Greg Yap as new partnerVentureBeat Menlo Ventures adds Greg Yap as Partner to Focus on Life Science Technology InvestingGlobeNewswire (press release) all 3 news articles »